BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 10522715)

  • 1. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
    Morton DL; Thompson JF; Essner R; Elashoff R; Stern SL; Nieweg OE; Roses DF; Karakousis CP; Mozzillo N; Reintgen D; Wang HJ; Glass EC; Cochran AJ
    Ann Surg; 1999 Oct; 230(4):453-63; discussion 463-5. PubMed ID: 10522715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
    Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
    Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.
    Essner R; Conforti A; Kelley MC; Wanek L; Stern S; Glass E; Morton DL
    Ann Surg Oncol; 1999; 6(5):442-9. PubMed ID: 10458681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
    Morton DL; Hoon DS; Cochran AJ; Turner RR; Essner R; Takeuchi H; Wanek LA; Glass E; Foshag LJ; Hsueh EC; Bilchik AJ; Elashoff D; Elashoff R
    Ann Surg; 2003 Oct; 238(4):538-49; discussion 549-50. PubMed ID: 14530725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
    Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concept of sentinel node localization: how it started.
    Morton DL; Chan AD
    Semin Nucl Med; 2000 Jan; 30(1):4-10. PubMed ID: 10656238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of sentinel lymph node identification: background and clinical implications.
    Cochran AJ; Essner R; Rose DM; Glass EC
    Langenbecks Arch Surg; 2000 Jul; 385(4):252-60. PubMed ID: 10958508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).
    Stitzenberg KB; Groben PA; Stern SL; Thomas NE; Hensing TA; Sansbury LB; Ollila DW
    Ann Surg Oncol; 2004 Oct; 11(10):900-6. PubMed ID: 15383424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.
    Essner R
    Expert Rev Anticancer Ther; 2010 May; 10(5):723-8. PubMed ID: 20470004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma.
    Haigh PI; Lucci A; Turner RR; Bostick PJ; Krasne DL; Stern SL; Morton DL
    Cancer; 2001 Aug; 92(3):535-41. PubMed ID: 11505397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized probe-directed sentinel node dissection in melanoma.
    Essner R; Bostick PJ; Glass EC; Foshag LJ; Haigh PI; Wang HJ; Morton DL
    Surgery; 2000 Jan; 127(1):26-31. PubMed ID: 10660755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?
    Yao KA; Hsueh EC; Essner R; Foshag LJ; Wanek LA; Morton DL
    Ann Surg; 2003 Nov; 238(5):743-7. PubMed ID: 14578738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of selective lymphadenectomy in the management of patients with malignant melanoma.
    Glass LF; Fenske NA; Messina JL; Cruse CW; Rapaport DP; Berman C; Puleo CA; Heller R; Miliotes G; Albertini J
    Dermatol Surg; 1995 Nov; 21(11):979-83. PubMed ID: 7582838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma.
    Kelemen PR; Essner R; Foshag LJ; Morton DL
    J Am Coll Surg; 1999 Sep; 189(3):247-52. PubMed ID: 10472924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
    Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node detection in malignant melanoma.
    Chan AD; Morton DL
    Recent Results Cancer Res; 2000; 157():161-77. PubMed ID: 10857170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas.
    Bleicher RJ; Essner R; Foshag LJ; Wanek LA; Morton DL
    J Clin Oncol; 2003 Apr; 21(7):1326-31. PubMed ID: 12663722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
    Faries MB; Bleicher RJ; Ye X; Essner R; Morton DL
    Arch Surg; 2004 Aug; 139(8):870-6; discussion 876-7. PubMed ID: 15302697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.
    Morton DL
    Clin Exp Metastasis; 2012 Oct; 29(7):699-706. PubMed ID: 22729520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymphadenectomy for patients with clinical stage I melanoma.
    Morton DL
    J Surg Oncol; 1997 Dec; 66(4):267-9. PubMed ID: 9425332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.